 was 2.9% for transfemoral CAS
and 1.7% for CEA (P ¼ .33), and major stroke and death was
identical in both groups at 0.6%. These results are considerably better than any other large study, including ACAS and
ACST, for both procedures. CREST and ACT-1 results
conﬁrm that CEA and CAS can be performed safely in carefully selected asymptomatic patients.
Similar to patients